The CRAFITY score: A new guidepost for prognosis prediction in patients with hepatocellular carcinoma undergoing immunotherapy
- 19 January 2022
- journal article
- letter
- Published by Elsevier in Journal of Hepatology
- Vol. 76 (5) , 1232-1233
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY scoreJournal of Hepatology, 2022
- Response Prediction in Immune Checkpoint Inhibitor Immunotherapy for Advanced Hepatocellular CarcinomaCancers, 2021
- Immunological inflammatory biomarkers as prognostic predictors for advanced hepatocellular carcinomaESMO Open, 2021
- Hepatocellular carcinomaNature Reviews Disease Primers, 2021
- Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2018
- Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)markerHeart, 2012
- Assessing the Performance of Prediction ModelsEpidemiology, 2010